The second pathway makes use of FAS (CD95) ligand secreted by the T lymphocytes, which upon binding to its receptor on tumor cells, leads to the formation of a death-inducing signaling complex followed by cell death (43–45). The gene discussed is FAS; the disease is neoplasm.